At Healthplan Pharma (India) Pvt. Ltd. we offer a comprehensive portfolio of high-quality pharmaceutical products designed to support healthcare professionals in delivering effective, reliable, and patient-centric care. Our product range spans key therapeutic areas with a strong focus on mental health, neurology, and supportive care, ensuring clinically relevant solutions across diverse patient needs.
Healthplan Pharma offers a focused and reliable range of antipsychotic and antimanic formulations designed to support the effective management of schizophrenia, psychotic disorders, and bipolar affective disorders. Our portfolio includes both typical and atypical antipsychotics, available in multiple strengths and formulations to meet diverse clinical needs.
Amisulpride Formulations
(Amisulpride)
Designed for the management of psychotic disorders, offering dose flexibility for initiation and maintenance therapy.
A conventional antipsychotic option for acute and chronic psychotic conditions.
Available as monotherapy and combination therapy to enhance tolerability.
Healthplan Pharma offers a focused range of anticonvulsant medicines formulated to support the management of seizure disorders, epilepsy, and related neurological conditions. The portfolio includes immediate-release and controlled-release formulations, providing flexibility for individualized dosing and long-term therapy.
Product Portfolio
Divalproex Sodium (Extended Release)
Formulated to support stable plasma levels and improved treatment adherence in seizure management.
A well-established anticonvulsant option for seizure management.
Healthplan Pharma offers a targeted cerebral activator formulation designed to support cognitive function and neurological performance. This product is commonly used as supportive therapy in conditions associated with impaired cognition, reduced cerebral metabolism, and neurological recovery.
The formulation is available in both tablet and syrup dosage forms, allowing flexibility in administration across different patient populations.
Product Portfolio
Piracetam-Based Formulation
Halotam® is formulated to support cerebral metabolism and cognitive function and is used as an adjunct in various neurological and cognitive conditions.
Used in the management of anxiety-related cardiovascular symptoms and stress responses.
Used in the management of sleep disorders, as prescribed.
Healthplan Pharma offers a targeted formulation to support the management of peripheral neuropathy, a condition commonly associated with diabetes, nutritional deficiencies, and nerve damage. The product is designed to aid in neuropathic symptom management and nerve health support as part of a comprehensive treatment plan prescribed by healthcare professionals.
Product Portfolio
Pregabalin + Methylcobalamin Combination
This fixed-dose combination is formulated to support relief from neuropathic symptoms while addressing underlying nerve health through vitamin B12 supplementation.
A comprehensive multivitamin and mineral formulation supporting nutritional replenishment.
Designed to support iron supplementation and hematinic requirements.
Formulated to support bone health and calcium metabolism.
A broad-spectrum antioxidant and micronutrient formulation.
Healthplan Pharma offers a dedicated appetizer formulation designed to support appetite stimulation and improve nutritional intake in patients experiencing reduced appetite. The product is commonly used as supportive therapy in conditions associated with poor appetite, nutritional deficiencies, and general debility, under medical supervision.
The formulation combines an appetite stimulant with supportive agents to aid digestion and nutritional absorption.
Product Portfolio
Cycoplan® – Syrup
Cycoplan® is formulated to help stimulate appetite while supporting digestive function and nutritional balance.
Healthplan Pharma offers a focused range of anticholinergic medicines used as supportive therapy in the management of movement-related side effects associated with antipsychotic treatment, including extrapyramidal symptoms. These formulations help improve patient comfort and treatment adherence when prescribed alongside primary psychiatric medications.
Product Portfolio
Triden® – Tablets
Triden® is commonly used to help manage drug-induced extrapyramidal symptoms in patients receiving antipsychotic therapy.
Used in the treatment of schizophrenia and bipolar disorder, including acute manic episodes.
Combination therapy formulated to support symptom control while helping manage extrapyramidal side effects.
Offers flexibility for patients requiring alternative dosage forms.
Healthplan Pharma offers a comprehensive and clinically relevant range of antidepressant formulations designed to support the treatment of depressive disorders, anxiety disorders, and associated psychiatric conditions. The portfolio spans multiple therapeutic classes, providing healthcare professionals with flexibility to individualize treatment based on patient symptoms, severity, and tolerability.
Our antidepressant range includes monotherapies and fixed-dose combinations, available in multiple strengths and dosage forms to support both initiation and maintenance therapy.
Product Portfolio
Imipramine-Based Formulations
Controlled-release combination designed for sustained anticonvulsant effect.
Used as adjunctive therapy in seizure disorders and related neurological indications.
Supports seizure control as monotherapy or adjunctive treatment.
Healthplan Pharma offers a focused range of sedative, tranquilizer, and anxiolytic formulations to support the management of anxiety disorders, stress-related conditions, sleep disturbances, and associated psychosomatic symptoms. The portfolio includes benzodiazepines, beta-blockers, and combination therapies, enabling clinicians to tailor treatment based on symptom profile and patient needs.
Product Portfolio
Alprazolam
Used in the management of anxiety and panic disorders.
Combination therapy designed to address both somatic and psychological symptoms of anxiety.
Commonly used for short-term relief of anxiety and insomnia associated with anxiety.
Healthplan Pharma offers a focused range of mood stabilizer formulations designed to support the long-term management of mood disorders, particularly bipolar affective disorder. These products are formulated to help stabilize mood fluctuations and support maintenance therapy under medical supervision.
Product Portfolio
Lithium Carbonate (Sustained Release)
These sustained-release formulations are designed for use in the maintenance treatment of mood disorders, as prescribed by healthcare professionals.
Healthplan Pharma offers a comprehensive range of vitamin and nutritional supplement formulations designed to support general health, nutritional balance, and specific deficiency states. The portfolio includes multivitamin syrups and capsule formulations, developed to complement clinical care across different age groups and health needs.
Product Portfolio
Multivitamin Syrups
Vita-Plan® – Syrup
Formulated to support overall nutritional supplementation and vitamin balance.
Healthplan Pharma offers a specialized neuroprotectant formulation designed to support nerve health and neurological function. The product is formulated to aid in conditions associated with nerve damage, oxidative stress, and nutritional deficiencies, and is commonly used as supportive therapy under medical supervision.
This formulation combines neurotropic vitamins, antioxidants, and trace elements, reflecting a comprehensive approach to neurological support.
Product Portfolio
BPlus® – Capsules
BPlus® is formulated to support nerve regeneration, antioxidant defense, and metabolic balance, and is commonly prescribed as adjunct therapy in neurological and neuropathic conditions.
Healthplan Pharma offers a targeted anti-ulcerant formulation designed to support the management of acid-related gastrointestinal disorders. The product is formulated to help reduce gastric acid secretion while supporting gastric motility, aiding symptom relief and patient comfort as part of prescribed therapy.
Product Portfolio
Docid-DSR® – Capsules
Docid-DSR® combines a proton pump inhibitor with a prokinetic agent to support effective management of gastro-esophageal reflux disease (GERD), acid peptic disorders, and related conditions.
Halodrin® 5 supports the management of movement disorders and muscle rigidity associated with antipsychotic-induced side effects.